Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Boehringer Ingelheim Selects ChemAxon to Power Next-Generation Global Cheminformatics Platform

Published: Friday, February 15, 2013
Last Updated: Friday, February 15, 2013
Bookmark and Share
Leading pharmaceutical company continues the trend of building future cheminformatics platforms on ChemAxon technology.

ChemAxon has announced that Boehringer Ingelheim has chosen its chemistry software platform for multiple applications across research and development, supporting in-house activities and work with external collaboration partners.

ChemAxon technology will be used to store, search, calculate, and visualize chemical entities, properties and reactions, helping to streamline the progression from drug discovery to clinical candidate.

ChemAxon was chosen after an extensive evaluation process that built on dimensions such as ROI, performance, robustness, scalability and future development roadmap.

ChemAxon sets the standard in chemically-intelligent software for pharmaceutical R&D.

With a client list that includes all of the top 15 global pharma companies, the company continues to experience significant growth year on year.

Commenting on the agreement, Alex Drijver, CEO of ChemAxon said, “The adoption of ChemAxon technology by Boehringer Ingelheim further underlines our position as the platform of choice for R&D organizations planning their next-generation systems.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ChemAxon, BSSN Software Partner
ChemAxon and BSSN Software GmbH are announcing a partnership that allows users to manage analytical data in ChemAxon's chemistry software solutions using open standards.
Thursday, June 18, 2015
InnoCentive Integrates ChemAxon's Marvin JS
This move will enable the convenient drawing of chemical structures and reactions/reaction mechanisms in InnoCentive’s innovation management software platform.
Friday, June 05, 2015
ChemAxon Provides Chemistry Informatics Platform for the European Lead Factory
ChemAxon will provide the core tools to support the pan European initiative.
Tuesday, June 18, 2013
ChemAxon Extends chemicalize.org Free Service with Predicted Data and User Customization
The new features help users understand better the chemical structure with more predicted properties and a customizable layout.
Monday, August 23, 2010
Broad Institute Acquires License to all ChemAxon Products and Deploys Across Chemical Biology Platform
License covers ChemAxon’s platform, discovery toolkits and desktop applications for institute-wide use.
Friday, August 20, 2010
ChemAxon Announces new CEO and Head of R&D
Company increases its focus on business development and market position with new appointments.
Tuesday, May 13, 2008
Migrating Chemical Information to New Architectures
New ChemAxon whitepaper discusses the drivers behind the increasing number of pharma and biotech companies moving from traditional proprietary chemical information systems to modern alternatives.
Monday, January 29, 2007
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!